The Cancer Vaccine That Could Save Moderna
For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma from returning in…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like The Journal. →
A New Milestone for U.S. Debt: $40 Trillion
US Treasury tries to soothe the bond market
Inside Moderna’s Personalized Cancer Vaccine
60%What an mRNA melanoma vaccine may mean for cancer treatment
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.